Other
Chidamide
0
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
Chidamide is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Unknown status9 · 64%
Recruiting3 · 21%
Not yet recruiting1 · 7%
Completed1 · 7%
Clinical Trials
Trial Activity
14 trials
Chidamide Bridging for CAR-T Therapy
Recruiting·—·Phase 1/2·NCT05370547·120 enrolled
Linperlisib Combined With Chidamide in Patients With PTCL
Recruiting·—·Phase 1/2·NCT06421948·134 enrolled
Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD
Unknown status·TThe First Affiliated Hospital of Soochow University·Phase 1/2·NCT05140616·20 enrolled
Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation
Unknown status·—·Phase 2·NCT02878278·24 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)